Intrinsic Value

Nymox Pharmaceutical Corporation (NYMX)


-0.00 (-0.05%)

Enterprise Value -2.01
Net Debt -1.23
Equity Value -0.78
Shares Outstanding 89.38
Equity Value Per Share -0.01

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt